Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Open accessThe DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
Importance: Lung cancer is the leading cause of cancer-related death in the US. Objective: To review the evidence on screening for lung cancer with low-dose computed tomography (LDCT) to inform the US Preventive Services Task Force (USPSTF). Data Sources: MEDLINE, Cochrane Library, and trial registries through May 2019; references; experts; and literature surveillance through November 20, 2020. Study Selection: English-language studies of screening with LDCT, accuracy of LDCT, risk prediction models, or treatment for early-stage lung cancer. Data Extraction and Synthesis: Dual review of abstracts, full-text articles, and study quality; qualitative synthesis of findings. Data were not pooled because of heterogeneity of populations and screening protocols. Main Outcomes and Measures: Lung cancer incidence, lung cancer mortality, all-cause mortality, test accuracy, and harms. Results: This review included 223 publications. Seven randomized clinical trials (RCTs) (N = 86 486) evaluated lung cancer screening with LDCT; the National Lung Screening Trial (NLST, N = 53 454) and Nederlands-Leuvens Longkanker Screenings Onderzoek (NELSON, N = 15 792) were the largest RCTs. Participants were more likely to benefit than the US screening-eligible population (eg, based on life expectancy). The NLST found a reduction in lung cancer mortality (incidence rate ratio [IRR], 0.85 [95% CI, 0.75-0.96]; number needed to screen [NNS] to prevent 1 lung cancer death, 323 over 6.5 years of follow-up) with 3 rounds of annual LDCT screening compared with chest radiograph for high-risk current and former smokers aged 55 to 74 years. NELSON found a reduction in lung cancer mortality (IRR, 0.75 [95% CI, 0.61-0.90]; NNS to prevent 1 lung cancer death of 130 over 10 years of follow-up) with 4 rounds of LDCT screening with increasing intervals compared with no screening for high-risk current and former smokers aged 50 to 74 years. Harms of screening included radiation-induced cancer, false-positive results leading to unnecessary tests and invasive procedures, overdiagnosis, incidental findings, and increases in distress. For every 1000 persons screened in the NLST, false-positive results led to 17 invasive procedures (number needed to harm, 59) and fewer than 1 person having a major complication. Overdiagnosis estimates varied greatly (0%-67% chance that a lung cancer was overdiagnosed). Incidental findings were common, and estimates varied widely (4.4%-40.7% of persons screened). Conclusions and Relevance: Screening high-risk persons with LDCT can reduce lung cancer mortality but also causes false-positive results leading to unnecessary tests and invasive procedures, overdiagnosis, incidental findings, increases in distress, and, rarely, radiation-induced cancers. Most studies reviewed did not use current nodule evaluation protocols, which might reduce false-positive results and invasive procedures for false-positive results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
The 2015 World Health Organization Classification of Lung Tumors
Travis, W. D., Brambilla, E., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, L. R., Dacic, S., Duhig, E., Flieder, D. B., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000630 · Cited by 4,520
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.1117 · Cited by 1,816
Survival of Patients with Stage I Lung Cancer Detected on CT Screening
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa060476 · Cited by 1,706
(2006) · Cancer · doi:10.1002/(issn)1097-0142 · Cited by 1,470
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
McWilliams, A., Tammemagi, M. C., Mayo, J. R., Roberts, H., Liu, G., Soghrati, K., Yasufuku, K., Martel, S., Laberge, F., Gingras, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214726 · Cited by 1,414
Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer
The National Lung Screening Trial Research Team (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209120 · Cited by 1,088
Human Development Report 2016 - Human Development for EveryonePreprint
Jahan, S. (2017) · RePEc: Research Papers in Economics · Cited by 833
Management of Lung Nodules Detected by Volume CT Scanning
van Klaveren, R. J., Oudkerk, M., Prokop, M., Scholten, E. T., Nackaerts, K., Vernhout, R., van Iersel, C. A., van den Bergh, K. A. M., van 't Westeinde, S., van der Aalst, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906085 · Cited by 820
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Patz, E. F., Pinsky, P., Gatsonis, C., Sicks, J. D., Kramer, B. S., Tammemägi, M. C., Chiles, C., Black, W. C., & Aberle, D. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12738 · Cited by 776
Alberg, A. J., Brock, M. V., Ford, J. G., Samet, J. M., & Spivack, S. D. (2013) · Chest · doi:10.1378/chest.12-2345 · Cited by 737
The Influence of Hospital Volume on Survival after Resection for Lung Cancer
Bach, P. B., Cramer, L. D., Schrag, D., Downey, R. J., Gelfand, S. E., & Begg, C. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450306 · Cited by 693
CT Screening for Lung Cancer: Five-year Prospective Experience
Swensen, S. J., Jett, J. R., Hartman, T. E., Midthun, D. E., Mandrekar, S. J., Hillman, S. L., Sykes, A.-M., Aughenbaugh, G. L., Bungum, A. O., & Allen, K. L. (2005) · Radiology · doi:10.1148/radiol.2351041662 · Cited by 636
Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
Kovalchik, S. A., Tammemagi, M., Berg, C. D., Caporaso, N. E., Riley, T. L., Korch, M., Silvestri, G. A., Chaturvedi, A. K., & Katki, H. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301851 · Cited by 575
Results of the Two Incidence Screenings in the National Lung Screening Trial
Aberle, D. R., DeMello, S., Berg, C. D., Black, W. C., Brewer, B., Church, T. R., Clingan, K. L., Duan, F., Fagerstrom, R. M., Gareen, I. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208962 · Cited by 550
Humphrey, L. L., Deffebach, M., Pappas, M., Baumann, C., Artis, K., Mitchell, J. P., Zakher, B., Fu, R., & Slatore, C. G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-00690 · Cited by 534
Performance of Lung-RADS in the National Lung Screening Trial: A Retrospective Assessment
Pinsky, P. F., Gierada, D. S., Black, W., Munden, R., Nath, H., Aberle, D., & Kazerooni, E. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2086 · Cited by 508
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial
(2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.05.044 · Cited by 464
Lung cancer mortality reduction by LDCT screening—Results from the randomized German LUSI trial
Becker, N., Motsch, E., Trotter, A., Heussel, C. P., Dienemann, H., Schnabel, P. A., Kauczor, H., Maldonado, S. G., Miller, A. B., Kaaks, R., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32486 · Cited by 449
Pedersen, J. H., Ashraf, H., Dirksen, A., Bach, K., Hansen, H., Toennesen, P., Thorsen, H., Brodersen, J., Skov, B. G., Døssing, M., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a0d98f · Cited by 434
Pastorino, U., Rossi, M., Rosato, V., Marchianò, A., Sverzellati, N., Morosi, C., Fabbri, A., Galeone, C., Negri, E., Sozzi, G., et al. (2012) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328351e1b6 · Cited by 414
Saghir, Z., Dirksen, A., Ashraf, H., Bach, K. S., Brodersen, J., Clementsen, P. F., Døssing, M., Hansen, H., Kofoed, K. F., Larsen, K. R., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200736 · Cited by 390
Horeweg, N., Scholten, E. T., de Jong, P. A., van der Aalst, C. M., Weenink, C., Lammers, J.-W. J., Nackaerts, K., Vliegenthart, R., ten Haaf, K., Yousaf-Khan, U. A., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70387-0 · Cited by 384
Infante, M., Cavuto, S., Lutman, F. R., Brambilla, G., Chiesa, G., Ceresoli, G., Passera, E., Angeli, E., Chiarenza, M., Aranzulla, G., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0076oc · Cited by 379
Implementation of Lung Cancer Screening in the Veterans Health Administration
Kinsinger, L. S., Anderson, C., Kim, J., Larson, M., Chan, S. H., King, H. A., Rice, K. L., Slatore, C. G., Tanner, N. T., Pittman, K., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9022 · Cited by 366
Infante, M., Cavuto, S., Lutman, F. R., Passera, E., Chiarenza, M., Chiesa, G., Brambilla, G., Angeli, E., Aranzulla, G., Chiti, A., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1475oc · Cited by 365
Nodule management protocol of the NELSON randomised lung cancer screening trial
Xu, D. M., Gietema, H., de Koning, H., Vernhout, R., Nackaerts, K., Prokop, M., Weenink, C., Lammers, J.-W., Groen, H., Oudkerk, M., et al. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.08.006 · Cited by 347
Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling
Wille, M. M. W., Dirksen, A., Ashraf, H., Saghir, Z., Bach, K. S., Brodersen, J., Clementsen, P. F., Hansen, H., Larsen, K. R., Mortensen, J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-1040oc · Cited by 341
Field, J. K., Duffy, S. W., Baldwin, D. R., Whynes, D. K., Devaraj, A., Brain, K. E., Eisen, T., Gosney, J., Green, B. A., Holemans, J. A., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207140 · Cited by 337
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial
Paci, E., Puliti, D., Lopes Pegna, A., Carrozzi, L., Picozzi, G., Falaschi, F., Pistelli, F., Aquilini, F., Ocello, C., Zappa, M., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209825 · Cited by 311
Field, J. K., Duffy, S. W., Baldwin, D. R., Brain, K. E., Devaraj, A., Eisen, T., Green, B. A., Holemans, J. A., Kavanagh, T., Kerr, K. M., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20400 · Cited by 296
Lopes Pegna, A., Picozzi, G., Mascalchi, M., Maria Carozzi, F., Carrozzi, L., Comin, C., Spinelli, C., Falaschi, F., Grazzini, M., Innocenti, F., et al. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.07.003 · Cited by 294
Pinsky, P. F., Church, T. R., Izmirlian, G., & Kramer, B. S. (2013) · Cancer · doi:10.1002/cncr.28326 · Cited by 293
Gohagan, J., Marcus, P., Fagerstrom, R., Pinsky, P., Kramer, B., & Prorok, P. (2004) · Chest · doi:10.1378/chest.126.1.114 · Cited by 279
Rampinelli, C., De Marco, P., Origgi, D., Maisonneuve, P., Casiraghi, M., Veronesi, G., Spaggiari, L., & Bellomi, M. (2017) · BMJ · doi:10.1136/bmj.j347 · Cited by 264
CT Screening for Lung Cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds
Yankelevitz, D. F., Yip, R., Smith, J. P., Liang, M., Liu, Y., Xu, D. M., Salvatore, M. M., Wolf, A. S., Flores, R. M., Henschke, C. I., et al. (2015) · Radiology · doi:10.1148/radiol.2015142554 · Cited by 255
NELSON lung cancer screening study
Ru Zhao, Y., Xie, X., de Koning, H. J., Mali, W. P., Vliegenthart, R., & Oudkerk, M. (2011) · Cancer Imaging · doi:10.1102/1470-7330.2011.9020 · Cited by 249
Women's Susceptibility to Tobacco Carcinogens and Survival After Diagnosis of Lung Cancer
International Early Lung Cancer Action Program Investigators (2006) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.296.2.180 · Cited by 247
Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial
Horeweg, N., van der Aalst, C. M., Vliegenthart, R., Zhao, Y., Xie, X., Scholten, E. T., Mali, W., Thunnissen, E., Weenink, C., Groen, H. J. M., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00197712 · Cited by 237
Wilson, D. O., Weissfeld, J. L., Fuhrman, C. R., Fisher, S. N., Balogh, P., Landreneau, R. J., Luketich, J. D., & Siegfried, J. M. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-336oc · Cited by 229
Walter, J. E., Heuvelmans, M. A., de Jong, P. A., Vliegenthart, R., van Ooijen, P. M. A., Peters, R. B., ten Haaf, K., Yousaf-Khan, U., van der Aalst, C. M., de Bock, G. H., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30069-9 · Cited by 226
Evaluating Shared Decision Making for Lung Cancer Screening
Brenner, A. T., Malo, T. L., Margolis, M., Elston Lafata, J., James, S., Vu, M. B., & Reuland, D. S. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.3054 · Cited by 226
Self-citationTammemagi, M. C., Schmidt, H., Martel, S., McWilliams, A., Goffin, J. R., Johnston, M. R., Nicholas, G., Tremblay, A., Bhatia, R., Liu, G., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30597-1 · Cited by 216
Lung cancer screening as a teachable moment for smoking cessation
Taylor, K. L., Cox, L. S., Zincke, N., Mehta, L., McGuire, C., & Gelmann, E. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2006.11.015 · Cited by 210
Henschke, C. I., Yip, R., Yankelevitz, D. F., Smith, J. P., & for the International Early Lung Cancer Action Program Investigators* (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-4-201302190-00004 · Cited by 205
Becker, N., Motsch, E., Gross, M.-L., Eigentopf, A., Heussel, C. P., Dienemann, H., Schnabel, P. A., Pilz, L., Eichinger, M., Optazaite, D.-E., et al. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1228-9 · Cited by 190
van der Aalst, C. M., van den Bergh, K. A. M., Willemsen, M. C., de Koning, H. J., & van Klaveren, R. J. (2010) · Thorax · doi:10.1136/thx.2009.133751 · Cited by 189
van Riel, S. J., Sánchez, C. I., Bankier, A. A., Naidich, D. P., Verschakelen, J., Scholten, E. T., de Jong, P. A., Jacobs, C., van Rikxoort, E., Peters-Bax, L., et al. (2015) · Radiology · doi:10.1148/radiol.2015142700 · Cited by 189
Veronesi, G., Bellomi, M., Mulshine, J. L., Pelosi, G., Scanagatta, P., Paganelli, G., Maisonneuve, P., Preda, L., Leo, F., Bertolotti, R., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.01.001 · Cited by 176
Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
van den Bergh, K. A. M., Essink-Bot, M. L., Borsboom, G. J. J. M., Th Scholten, E., Prokop, M., de Koning, H. J., & van Klaveren, R. J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605459 · Cited by 172
Ashraf, H., Tonnesen, P., Holst Pedersen, J., Dirksen, A., Thorsen, H., & Dossing, M. (2009) · Thorax · doi:10.1136/thx.2008.102475 · Cited by 172
Estimating Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer: A Cohort Study
Veronesi, G., Maisonneuve, P., Bellomi, M., Rampinelli, C., Durli, I., Bertolotti, R., & Spaggiari, L. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-11-201212040-00005 · Cited by 162
Tanner, N. T., Gebregziabher, M., Hughes Halbert, C., Payne, E., Egede, L. E., & Silvestri, G. A. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0259oc · Cited by 159
Gareen, I. F., Duan, F., Greco, E. M., Snyder, B. S., Boiselle, P. M., Park, E. R., Fryback, D. G., & Gatsonis, C. A. (2014) · Cancer · doi:10.1002/cncr.28833 · Cited by 157
Cumulative Incidence of False-Positive Test Results in Lung Cancer Screening
Croswell, J. M., Baker, S. G., Marcus, P. M., Clapp, J. D., & Kramer, B. S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-8-201004200-00007 · Cited by 156
Young, R. P., Duan, F., Chiles, C., Hopkins, R. J., Gamble, G. D., Greco, E. M., Gatsonis, C. A., & Aberle, D. R. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0894oc · Cited by 151
Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography
Toyoda, Y., Nakayama, T., Kusunoki, Y., Iso, H., & Suzuki, T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604351 · Cited by 148
Becker, N., Motsch, E., Gross, M.-L., Eigentopf, A., Heußel, C. P., Dienemann, H., Schnabel, P. A., Eichinger, M., Optazaite, D.-E., Puderbach, M., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000530 · Cited by 146
Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial
Pegna, A. L., Picozzi, G., Falaschi, F., Carrozzi, L., Falchini, M., Carozzi, F., Pistelli, F., Comin, C., Deliperi, A., Grazzini, M., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828f68d6 · Cited by 144
Comparative Effectiveness Review Methods: Clinical Heterogeneity
West, S. L., Gartlehner, G., Mansfield, A. J., Poole, C., Tant, E. M., Lenfestey, N. F., Lux, L. J., Amoozegar, J. B., Morton, S. C., Carey, T. C., et al. (2010) · Cited by 137
Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening
Byrne, M. M., Weissfeld, J., & Roberts, M. S. (2008) · Medical Decision Making · doi:10.1177/0272989x08322013 · Cited by 135
van den Bergh, K. A. M., Essink‐Bot, M., Borsboom, G. J. J. M., Scholten, E. T., van Klaveren, R. J., & de Koning, H. J. (2010) · European Respiratory Journal · doi:10.1183/09031936.00123410 · Cited by 133
Morgan, L., Choi, H., Reid, M., Khawaja, A. I., & Mazzone, P. J. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201612-1023oc · Cited by 129
CT Screening for Lung Cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds
Henschke, C. I., Yip, R., Smith, J. P., Wolf, A., Flores, R. M., Liang, M., Salvatore, M. M., Liu, Y., Xu, D. M., Yankelevitz, D. F., et al. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.16.16043 · Cited by 127
van den Bergh, K. A. M., Essink‐Bot, M., Bunge, E. M., Scholten, E. T., Prokop, M., van Iersel, C. A., van Klaveren, R. J., & de Koning, H. J. (2008) · Cancer · doi:10.1002/cncr.23590 · Cited by 126
Sverzellati, N., Silva, M., Calareso, G., Galeone, C., Marchianò, A. V., Sestini, S., Sozzi, G., & Pastorino, U. (2016) · European Radiology · doi:10.1007/s00330-016-4228-3 · Cited by 123
Townsend, C. O., Clark, M. M., Jett, J. R., Patten, C. A., Schroeder, D. R., Nirelli, L. M., Swensen, S. J., & Hurt, R. D. (2005) · Cancer · doi:10.1002/cncr.21045 · Cited by 121
Computed tomographic characteristics of interval and post screen carcinomas in lung cancer screening
Scholten, E. T., Horeweg, N., de Koning, H. J., Vliegenthart, R., Oudkerk, M., Mali, W. P. T. M., & de Jong, P. A. (2014) · European Radiology · doi:10.1007/s00330-014-3394-4 · Cited by 120
Yip, R., Henschke, C. I., Yankelevitz, D. F., & Smith, J. P. (2014) · Radiology · doi:10.1148/radiol.14132950 · Cited by 117
Nyssen, O. P., Taylor, S. J., Wong, G., Steed, E., Bourke, L., Lord, J., Ross, C. A., Hayman, S., Field, V., Higgins, A., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20270 · Cited by 115
Menezes, R. J., Roberts, H. C., Paul, N. S., McGregor, M., Chung, T. B., Patsios, D., Weisbrod, G. L., Herman, S. J., Pereira, A., McGregor, A., et al. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.03.030 · Cited by 111
The impact of a lung cancer computed tomography screening result on smoking abstinence
van der Aalst, C. M., van Klaveren, R. J., van den Bergh, K. A. M., Willemsen, M. C., & de Koning, H. J. (2010) · European Respiratory Journal · doi:10.1183/09031936.00035410 · Cited by 103
Ashraf, H., Saghir, Z., Dirksen, A., Pedersen, J. H., Thomsen, L. H., Døssing, M., & Tønnesen, P. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-203849 · Cited by 102
National Lung Screening Trial Findings by Age: Medicare-Eligible Versus Under-65 Population
Pinsky, P. F., Gierada, D. S., Hocking, W. G., Patz, E. F., & Kramer, B. S. (2014) · Annals of Internal Medicine · doi:10.7326/m14-1484 · Cited by 98
A pre-post study testing a lung cancer screening decision aid in primary care
Reuland, D. S., Cubillos, L., Brenner, A. T., Harris, R., Minish, B., & Pignone, M. P. (2018) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-018-0582-1 · Cited by 97
Self-citationChange in smoking status after spiral chest computed tomography scan screening
Cox, L. S., Clark, M. M., Jett, J. R., Patten, C. A., Schroeder, D. R., Nirelli, L. M., Swensen, S. J., & Hurt, R. D. (2003) · Cancer · doi:10.1002/cncr.11813 · Cited by 94
Heuvelmans, M. A., Oudkerk, M., de Bock, G. H., de Koning, H. J., Xie, X., van Ooijen, P. M. A., Greuter, M. J. W., de Jong, P. A., Groen, H. J. M., & Vliegenthart, R. (2013) · European Radiology · doi:10.1007/s00330-013-2799-9 · Cited by 86
National Lung Screening Trial: Variability in Nodule Detection Rates in Chest CT Studies
Pinsky, P. F., Gierada, D. S., Nath, P. H., Kazerooni, E. A., & Amorosa, J. K. (2013) · Radiology · doi:10.1148/radiol.13121530 · Cited by 86
Heleno, B., Siersma, V., & Brodersen, J. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.3056 · Cited by 86
Smoking Cessation and Relapse during a Lung Cancer Screening Program
Anderson, C. M., Yip, R., Henschke, C. I., Yankelevitz, D. F., Ostroff, J. S., & Burns, D. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0176 · Cited by 82
Nguyen, X. V., Davies, L., Eastwood, J. D., & Hoang, J. K. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2016.09.044 · Cited by 79
Howard, D. H., Richards, T. B., Bach, P. B., Kegler, M. C., & Berg, C. J. (2015) · Cancer · doi:10.1002/cncr.29677 · Cited by 76
Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial
Frille, A., Hardavella, G., & Lee, R. (2020) · Breathe · doi:10.1183/20734735.0322-2019 · Cited by 76
Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST)
Rasmussen, J. F., Siersma, V., Pedersen, J. H., & Brodersen, J. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.11.003 · Cited by 75
Styn, M. A., Land, S. R., Perkins, K. A., Wilson, D. O., Romkes, M., & Weissfeld, J. L. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0895 · Cited by 72
Challenges Implementing Lung Cancer Screening in Federally Qualified Health Centers
Zeliadt, S. B., Hoffman, R. M., Birkby, G. M., Eberth, J. M., Brenner, A. T., Reuland, D. S., & Flocke, S. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.01.001 · Cited by 70
Self-citationMascalchi, M., Belli, G., Zappa, M., Picozzi, G., Falchini, M., Nave, R. D., Allescia, G., Masi, A. C., Pegna, A. L., Villari, N., et al. (2006) · American Journal of Roentgenology · doi:10.2214/ajr.05.0088 · Cited by 68
Schabath, M. B., Massion, P. P., Thompson, Z., Eschrich, S. A., Balagurunathan, Y., Goldof, D., Aberle, D. R., & Gillies, R. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159880 · Cited by 64
Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial
Aggestrup, L. M., Hestbech, M. S., Siersma, V., Pedersen, J. H., & Brodersen, J. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000663 · Cited by 54
Lung Cancer Mortality in the Lung Screening Study Feasibility Trial
Doroudi, M., Pinsky, P. F., & Marcus, P. M. (2018) · JNCI Cancer Spectrum · doi:10.1093/jncics/pky042 · Cited by 50
Clark, M. A., Gorelick, J. J., Sicks, J. D., Park, E. R., Graham, A. L., Abrams, D. B., & Gareen, I. F. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv037 · Cited by 46
Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study
Thalanayar, P. M., Altıntaş, N., Weissfeld, J. L., Fuhrman, C. R., & Wilson, D. O. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201412-577oc · Cited by 34
Gierada, D. S., Pinsky, P. F., Duan, F., Garg, K., Hart, E. M., Kazerooni, E. A., Nath, H. P., Watts, J. R., & Aberle, D. R. (2017) · European Radiology · doi:10.1007/s00330-016-4705-8 · Cited by 30
Wang, Y., van Klaveren, R. J., de Bock, G. H., Zhao, Y., Vernhout, R. M., Leusveld, A. L. M., Scholten, E. T., Verschakelen, J., Mali, W. P. T. M., de Koning, H. J., et al. (2011) · Radiology · doi:10.1148/radiol.11102289 · Cited by 28
ROC Curves for Low-Dose CT in the National Lung Screening Trial
Pinsky, P. F., Gierada, D. S., Nath, H. P., Kazerooni, E. A., & Amorosa, J. K. (2013) · Journal of Medical Screening · doi:10.1177/0969141313500666 · Cited by 22
Meza, R., Jeon, J., Toumazis, I., et al. (2021) · Europe PMC (PubMed Central) · Cited by 11
Cited by
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.1117 · Cited by 1,816
Kratzer, T. B., Bandi, P., Freedman, N. D., Smith, R. A., Travis, W. D., Jemal, A., & Siegel, R. L. (2024) · Cancer · doi:10.1002/cncr.35128 · Cited by 512
Evaluating the Patient With a Pulmonary Nodule: A Review
Mazzone, P. J., & Lam, L. (2022) · JAMA · doi:10.1001/jama.2021.24287 · Cited by 487
Zhou, J., Xu, Y., Liu, J., Feng, L., Yu, J., & Chen, D. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102693 · Cited by 389
Screening for lung cancer: 2023 guideline update from the American Cancer Society
Wolf, A. M. D., Oeffinger, K. C., Shih, T. Y., Walter, L. C., Church, T. R., Fontham, E. T. H., Elkin, E. B., Etzioni, R. D., Guerra, C. E., Perkins, R. B., et al. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21811 · Cited by 310
Metadata
- Authors
- Jonas, D. E., Reuland, D. S., Reddy, S. M., Nagle, M., Clark, S. D., Weber, R. P., Enyioha, C., Malo, T. L., Brenner, A. T., Armstrong, C., Coker-Schwimmer, M., Middleton, J. C., Voisin, C., & Harris, R. P.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2021-03-09
- Volume
- 325
- Issue
- 10
- Pages
- 971
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3134447409
- Cited by
- 633
- References
- 99
- FWCI
- 53.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.